Condition

Cardiac Sarcoidosis clinical trials and research

• 13Clinical trials
• 5NIH research projects
• 10Countries

Newest Cardiac Sarcoidosis clinical trials

All recruiting trials (13)

• Al[18F]F-NOTA-folate PET imaging in suspected cardiac sarcoidosis and infective endocarditis

  This diagnostic test uses a folate-based PET tracer to see if it can help identify inflammation or infection in the heart for people with suspected cardiac sarcoidosis or infective endocarditis.

  Recruiting Turku University Hospital · Turku · NCT07814222

• Exosome-based biomarkers for cardiac sarcoidosis activity

  Researchers will test blood exosomes to see if they reveal activity of cardiac sarcoidosis in patients with and without the condition, using usual care FDG-PET data.

  Recruiting Mayo Clinic · Rochester, Minnesota · NCT07604220

• Using advanced heart MRI to improve diagnosis and risk prediction for rare cardiomyopathies

  This project tests whether advanced cardiac MRI techniques can help diagnose and predict future risk for people with rare heart muscle diseases like Danon, Fabry, cardiac amyloidosis, Noonan syndrome, and cardiac sarcoidosis.

  Recruiting Chinese Academy of Medical Sciences, Fuwai Hospital · Beijing · NCT07336394

• Tc-99m Tilmanocept SPECT/CT imaging for detecting cardiac sarcoidosis

  This trial tries to see if a Tc-99m Tilmanocept SPECT/CT scan can detect cardiac sarcoidosis in adults.

  Recruiting Phase 2 Duke University · Durham, North Carolina · NCT07159074

• Evaluating rilonacept for treating cardiac sarcoidosis

  This study tests if adding a new drug called rilonacept to regular treatment can help adults with cardiac sarcoidosis reduce inflammation in their hearts.

  Recruiting at 2 sites Phase 2 Mayo Clinic · Baltimore, Maryland and 1 other locations · NCT06660732

• Using SGLT1/2 inhibitors to improve heart imaging in healthy volunteers

  This study is testing whether a new diabetes medication can help improve heart imaging in healthy volunteers by better controlling how the heart uses sugar during scans.

  Recruiting University of Pennsylvania · Philadelphia, Pennsylvania · NCT06510894

• Using advanced imaging to evaluate heart muscle scarring in various heart conditions

  This study is testing a new imaging method to see how heart scarring changes over time in people with certain heart conditions.

  Recruiting University of Edinburgh · Edinburgh, Scotland · NCT06409585

• Imaging activated macrophages in cardiac sarcoidosis using 64Cu-DOTATATE

  This study is testing a new type of PET/CT scan using a special tracer to see if it can better identify heart inflammation caused by sarcoidosis in patients who may have the condition.

  Recruiting Copenhagen University Hospital, Rigshospitalet · Copenhagen · NCT06131112

• Evaluating PET/MRI for cardiac sarcoidosis prognosis

  This study is testing if using a special imaging technique called PET/MRI can help doctors better understand and treat people with cardiac sarcoidosis by predicting their risk of serious heart problems.

  Recruiting Assistance Publique - Hôpitaux de Paris · Créteil · NCT05954507

• Evaluating diagnostic criteria for cardiac sarcoidosis

  This study is testing how well current methods for diagnosing cardiac sarcoidosis work to help find patients who might need treatment sooner.

  Recruiting Heart Center Leipzig - University Hospital · Leipzig · NCT04737317

• Comparing low dose Prednisone and Methotrexate to standard dose Prednisone for cardiac sarcoidosis

  This study is testing whether a low dose of Prednisone combined with Methotrexate can help people with cardiac sarcoidosis just as well as a standard dose of Prednisone, while also making them feel better and reducing side effects.

  Recruiting at 26 sites Phase 3 Ottawa Heart Institute Research Corporation · New Haven, Connecticut and 30 other locations · NCT03593759

• Registry and biobank for arrhythmogenic ventricular cardiomyopathy

  This study is trying to gather information and samples from people with arrhythmogenic ventricular cardiomyopathy and their families to better understand the genetic causes of the condition and improve early diagnosis for those at risk.

  Recruiting at 2 sites Mayo Clinic · Rochester, Minnesota and 1 other locations · NCT03049254

• Observing cardiac sarcoidosis in patients

  This study looks at patients with cardiac sarcoidosis and those at risk for it to see how the disease progresses and how treatments like corticosteroids affect them.

  Recruiting at 13 sites Ottawa Heart Institute Research Corporation · Calgary, Alberta and 13 other locations · NCT01477359

NIH-funded research (5)

Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.

• Advanced imaging to monitor immune-suppressant therapy in active cardiac sarcoidosis

  A patient-focused imaging study to see how MRI and PET 18F-FDG can track how well immune-suppressant treatment is working for active cardiac sarcoidosis.

  NIH research Icahn School of Medicine at Mount Sinai · New York, United States · NIH-11392382

• Precision PET attenuation correction for heart PET/MR imaging

  Aimed at improving PET/MR heart imaging by perfecting how PET signals are corrected for tissue, so patients get accurate results in one combined test instead of separate scans.

  NIH research Ut Southwestern Medical Center · Dallas, United States · NIH-11378430

• CXCR3 Blockade as a Targeted Therapy for Cardiac Sarcoidosis

  A study to see if blocking CXCR3 can help treat heart involvement in sarcoidosis patients using advanced immune profiling and a mouse model.

  NIH research Stanford University · Stanford, United States · NIH-11372257

• MRI and PET scans to track treatment response in active cardiac sarcoidosis

  This project uses PET and MRI scans with advanced imaging measures and AI to monitor how people with active cardiac sarcoidosis respond to immune-suppressing treatments.

  NIH research Icahn School of Medicine at Mount Sinai · New York, United States · NIH-11141926

• Investigating imaging responses to immune suppressant therapy in cardiac sarcoidosis patients

  This study is looking at how well certain imaging tests can show if patients with cardiac sarcoidosis are responding to their immune-suppressing treatments, with the goal of finding better ways to help them feel better.

  NIH research Icahn School of Medicine at Mount Sinai · New York, United States · NIH-10999907

Related topics

Quick answers

How many Cardiac Sarcoidosis clinical trials are recruiting right now?

13, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 10 countries. The most sites are in United States (6 trials), United Kingdom (3 trials), Canada (2 trials), Japan (2 trials), France (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 2, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →